Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
58.00
-1.59 (-2.67%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $1.85 billion as of April 25, 2025. Its market cap has increased by 59.80% in one year.
Market Cap
1.85B
Enterprise Value
1.71B
1-Year Change
59.80%
Ranking
Category
Stock Price
$58.00
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $1.85B, an increase of 1,182.34%. That is a compound annual growth rate of 134.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 1.85B | -4.85% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.47B |
| UnitedHealth Group | 393.47B |
| Johnson & Johnson | 373.70B |
| AbbVie | 312.05B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.87B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |